Donate to Remove ads

Got a credit card? use our Credit Card & Finance Calculators

Thanks to 87investor,longview,Sussexlad,niord,staffordian, for Donating to support the site

MrC's Smallcap Sweeps for Sept 2020

Discuss Shares, buying selling, tips and deals
MrContrarian
Lemon Slice
Posts: 958
Joined: November 4th, 2016, 2:45 pm
Has thanked: 33 times
Been thanked: 902 times

MrC's Smallcap Sweeps for Sept 2020

#337310

Postby MrContrarian » September 1st, 2020, 7:43 am

Smallcap Sweep. 01-Sep-20
AA T/O PUSU extended

Urban Logistics REIT (SHED) plans fundraise for more acquisitions. [SP=146.5 Cap=276m]
Nanoco (NANO) CEO resigns but will remain available to the Company as a Special Advisor, He is thanked. CFO becomes CEO. [SP=16.8 Cap=51m]
Immotion (IMMO)ImmotionVR sites have operated on limited opening times, but have all traded strongly, generating a profitable contribution after all local costs. A number of attractions in key Partner sites still closed. Expects to launch the Let's Explore in-home consumer product later this month. [SP=4.6 Cap=17m]
Location Sciences (LSAI) wins first customer to its Verify Audience platform. [SP=0.44 Cap=2m]
Gear4music (G4M) last 2 months trading has remained strong, guides FY at least in line with recently upgraded expectations. [SP=565 Cap=118m]
Cake Box (CBOX) last 3 month LFL rev up c.14% in franchise stores. Online up 74%. Will pay special dividend equal to the withdrawn final div.. [SP=176.4 Cap=71m]
AA (AA.) Discussions with each of the Potential Offerors have continued to progress and their due diligence is on-going. PUSU deadline extended to 29 Sept. [SP=34.7 Cap=216m]
AFC Energy (AFC) sells bespoke 100kW alkaline fuel cell system for delivery and commissioning in Q3 2021. Mainly funded by German govt. No £££. [SP=19.5 Cap=132m]
Cambridge Cognition (COG) wins £2m contract for three late phase schizophrenia trials. [SP=39.5 Cap=12m]
Image Scan (IGE) H2 better than expected. Guides FY rev £3.3m to £3.5m, profit 0 to £100k. [SP=2.4 Cap=3m]
Eden Research (EDEN) gets regulatory approval for anti nematode product Cedroz in Spain. [SP=6.7 Cap=25m]
Induction Healthcare (INHC) subsidiary Horizon achieves earn-out target ahead of schedule, triggering £1.5m payment. [SP=89.95 Cap=37m]
Avation (AVAP) Virgin Australia unsecured creditors to get 9%-13%. AVAP claims $74.7m. Five of the 13 aircraft have been re-leased. [SP=125 Cap=78m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian
read it first on Twitter https://twitter.com/MrContrarian

MrContrarian
Lemon Slice
Posts: 958
Joined: November 4th, 2016, 2:45 pm
Has thanked: 33 times
Been thanked: 902 times

Re: MrC's Smallcap Sweeps for Sept 2020

#337534

Postby MrContrarian » September 2nd, 2020, 7:31 am

Smallcap Sweep. 02-Sep-20


Immupharma (IMM) £6,5m placing at 11p, a 33% discount, to keep the lights on. [SP=16.5 Cap=30m]
Zoetic (ZOE) sells remaining interest in its oil and gas assets for $20k, net of debt. Also in final negotiations of a second CBD international distribution contract. [SP=17.6 Cap=34m]
Redcentric (RCN) confirms reports of bid talks but is also evaluating potential options in relation to organic growth and/or potential acquisitions that might be made. Expects formal sale process to end by Q4. [SP=142 Cap=220m]
Oncimmune (ONC) has signed an autoantibody profiling collaboration with a leading global biopharmaceutical co to complete in Q2 2021. No £££. [SP=146.5 Cap=93m]
Pendragon (PDG) conclusions of strategy review - cost cuts, efficiency improvements and to grow and diversify Pinewood, a SaaS dealer management system and CRM tool. Also it plans to 'Disrupt standalone used cars' utilising leverage and whatnot. [SP=8 Cap=112m]
Cambria Automobiles (CAMB) June and July trading well ahead of the previous year and management expectations. But "order bank for September is building at a slower rate than the previous year and the Board has concerns around the broader economy and customer confidence." [SP=52.49 Cap=52m]

In line: GHH
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Slice
Posts: 958
Joined: November 4th, 2016, 2:45 pm
Has thanked: 33 times
Been thanked: 902 times

Re: MrC's Smallcap Sweeps for Sept 2020

#337796

Postby MrContrarian » September 3rd, 2020, 7:48 am

Smallcap Sweep. 03-Sep-20


Revolution Bars (RBG) trading since reopening has been ahead of mgmt expectations, in part due to Eat Out To Help Out. Comparable venue sales in last 8 weeks down 28% cf planned base case of down 45%. EOTHO sales up 88%. Still in talks over rents. However mgm expectations for this FY remain unchanged. [SP=14.5 Cap=18m]
RPS (RPS) placing at 44p, a 16% premium, to reduce debt and working capital. New debt agreements. [SP=38 Cap=87m]
Allergy Therapeutics (AGY) secures virus-like particle ("VLP") technology platform to broaden vaccine pipeline through licensing agreements with Saiba and DeepVax. The upfront payments are not material for the co.# [SP=18 Cap=115m]
Costain (COST) A465 contact dispute gets worse. Arbitrator fins that additional costs associated with the building of a retaining wall is not a compensation event for the co. This "has implications for the responsibility for design information under the whole contract and therefore Costain's ability to recover these costs." H1 will include a c.£45m charge to cover this. [SP=52.2 Cap=144m]
7digital (7DIG) £5m placing at 2.25p, a 24% discount, to support immediate and medium term commercial growth opportunities. [SP=3.08 Cap=76m]
Sensyne Health (SENS) has launched its 'SENSE' system in the UK, developed in partnership with Microsoft and its health cloud technology, as part of an existing strategic partnership. SENSE is AI system to help doctors make diagnoses. [SP=75 Cap=96m]
Miton UK MicroCap Trust (MINI) NAV up 19% YTD to 63.71p, at 1 Sept. [SP=56.18 Cap=78m]
Yourgene Health (YGEN) launches IONA Nx NIPT workflow, a non-invasive prenatal test, for DNA testing. [SP=16.92 Cap=122m]
Omega Diagnostics (ODX) has CE-Marked Mologic lateral flow antibody test for COVID-19 for sale under Omega's VISITECT brand. Test checks 3 antibodies for better sensitivity. [SP=58.4 Cap=104m]
Parity (PTY) framework agreement: pre-qualified supplier on two additional Lots on the Digital and Technology Services Dynamic Purchasing System for the Scottish Government. No £££. [SP=7.85 Cap=8m]
Kropz (KRPZ) appeal hearing against Elandsfontein's valid integrated water use licence is postponed. [SP=7.15 Cap=36m]
Catena (CTNA) extends exercise period for the option it holds to increase its shareholding in Insight, the data science and machine learning solutions company. Discusing buying all the shares. Shares suspended. [SP=61 Cap=24m]
Severfield (SFR) AGM stmt. "Tendering and pipeline activity remain encouraging despite some client investment decisions being deferred...cautiously optimistic. Final div 1.8p. [SP=55.2 Cap=170m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Slice
Posts: 958
Joined: November 4th, 2016, 2:45 pm
Has thanked: 33 times
Been thanked: 902 times

Re: MrC's Smallcap Sweeps for Sept 2020

#338023

Postby MrContrarian » September 4th, 2020, 7:25 am

Smallcap Sweep. 04-Sep-20


Novacyt (NCYT) as trailed, has launched a CE-Mark approved polymerase chain reaction (PCR) two gene target test for COVID-19, as required by France, Belgium, Croatia, Poland and the UAE. [SP=300 Cap=233m]
Filta (FLTA) exclusive licencing agreement with NTH Solutions, a support services group owned by an NHS Trust, to utilise its hypochlorous acid based broad-spectrum disinfectant. "Filta employees will be fully trained by NHS decontamination experts and will have exclusive rights to both sell the products and provide training for customers in NHS best practices for proper use of the disinfectants." [SP=88 Cap=26m]
Renew (RNWH) guides FY materially ahead of market expectations with adj operating profit £39m-£40m and a net cash position at the year end, ahead of market expectations. [SP=422 Cap=332m]
Redde Northgate (REDD) buys certain businesses and certain assets of Nationwide Accident Repair Services for £11m + £5m contingent. Expected to be earnings enhancing in the first full year. Trading: "sequential monthly improvements in trading, such that the level of support packages provided to customers has now reduced to a minimal level, vehicles on hire have increased in all countries, accident and incident volumes have started to increase." [SP=191 Cap=470m]
CyanConnode (CYAN) FY. Outlook "at an advanced stage of agreeing a significant contract for a large number of units." [SP=3.95 Cap=7m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Slice
Posts: 958
Joined: November 4th, 2016, 2:45 pm
Has thanked: 33 times
Been thanked: 902 times

Re: MrC's Smallcap Sweeps for Sept 2020

#338671

Postby MrContrarian » September 7th, 2020, 7:38 am

Smallcap Sweep. 07-Sep-20


Spectra Systems (SPSY) FY. Guides this FY revenue and earnings to significantly exceed market expectations. [SP=129 Cap=59m]
Telit Communications (TCM) CFO scarpers. He is thanked. [SP=140 Cap=186m]
CyanConnode (CYAN) order for 350,000 modules in India worth INR 1.8bn or £18m. [SP=4.44 Cap=8m]
Destiny Pharma (DEST) collaboration and Innovate UK grant award to co-develop novel, preventative treatment for covid via a nasal spray of a bacterium. SPOR-COV has already been shown by collaborator SporeGen to provide complete protection in preclinical models (???) of influenza virus. [SP=48 Cap=21m]
NAHL (NAH) CEO scarpers, immediate effect. He is thanked. [SP=39 Cap=18m]
Omega Diagnostics (ODX) completes self-test usability study for the UK Rapid Test Consortium's COVID-19 lateral flow antibody test. "Omega remains on track to have production capacity in place this month to produce an initial 100,000 AbC-19 Rapid test per week, scaling up to 200,000 tests per week capacity in October." [SP=53.99 Cap=96m]
Amigo (AMGO) fight update: notes Tweet from James Benamor re irrevocable instruction which his vehicle Richmond Group Limited has purportedly entered into with its broker to acquire up to 29% of co, conditional on Benamor being appointed CEO. [SP=12.7 Cap=60m]
Quadrise Fuels International (QFI) update on progess. Nothing big. [SP=2.81 Cap=30m]
UP Global Sourcing (UPGS) guides FY rev down 6%, U/L pretax excluding the furlough credit down 2.7% to £8.2m. FY21 order book up YoY. No longer utilising the Government Time to Pay and VAT deferral schemes. [SP=102 Cap=84m]
Fox Marble (FOX) recommencing operations in its Cervenille quarry in Kosovo due to orders for Grigio Argento marble. [SP=2 Cap=7m]
Byotrol (BYOT) £350k grant from Innovate UK to further investigate the anti-viral properties of certain common forms of seaweed. [SP=8.5 Cap=38m]
SRT Marine Systems (SRT) FY loss £3m (excluding one-off impairment charge on Middle Eastern project of £3.9m) - 'very disappointing', as expected but jam tomorrow. [SP=41.98 Cap=69m]

In line: TLY
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Slice
Posts: 958
Joined: November 4th, 2016, 2:45 pm
Has thanked: 33 times
Been thanked: 902 times

Re: MrC's Smallcap Sweeps for Sept 2020

#338862

Postby MrContrarian » September 8th, 2020, 7:47 am

Smallcap Sweep. 08-Sep-20
Hydrogen goes off

ScS (SCS) last 6 weeks LFL order intake up 51% , "significantly exceeded our expectations." [SP=156 Cap=59m]
Silence Therapeutics (SLN) update on two drugs. Also ADSs start trading on NASDAQ today. [SP=455 Cap=377m]
Verona Pharma (VRP) pilot study to test ensifentrine delivered via inhaler formulation in U.S. patients hospitalized [sic] with covid. "Ensifentrine is a first-in-class product candidate that combines bronchodilator and anti-inflammatory activities in one compound." [SP=63 Cap=261m]
DWF Group (DWF) Q1(July) rev up 20%, pretax -£0.6m (+£1.9m), adj pretax £7.4m (£2.2m). FCF £18.5m. [SP=60.52 Cap=196m]
Synairgen (SNG) positive data from interim analysis of SNG001 trial in COPD patients, "provides a strong rationale for assessing SNG001 in COPD patients admitted to hospital with exacerbations from confirmed viral lung infections...discussions with a number of regulatory agencies worldwide to establish the regulatory route to the approval of SNG001 as a treatment for COVID-19." [SP=196 Cap=293m]
Newmark Security (NWT) wins contracts with two existing clients. A 2 year £1.3m deal and a 3 year £400k one. [SP=1.24 Cap=6m]
Bigblu Broadband (BBB) gets £7.6m grant for £9.11m spend on fibre and fixed wireless networks in Yorkshire. [SP=88 Cap=51m]
Hydrogen (HYDG) proposes delisting. Tender offer at 40p for up to 56% of co, a 43% premium. [SP=26.04 Cap=9m]
i-nexus Global (INX) operating at monthly P&L break-even due to further cost cuts. Wins two contracts. Co "unable to secure access to additional funding. Based on the Company's latest cash flow projections...anticipates that the Company is likely to experience a modest cash shortfall by the end of the calendar year, but should return to a positive cash balance from February 2021." [SP=3.22 Cap=1m]
Seeing Machines (SEE) signs MoU with large semiconductor co to license Occula Neural Processing Unit for vehicle interior monitoring. [SP=3.6 Cap=121m]
BP Marsh (BPM) H1 ended with 22 new investment opportunities presented to co (49), "to be expected given the challenges." Many updates. [SP=238 Cap=89m]
Surgical Innovations (SUN) H1(June) rev down 49% to to £2.59m, adj EPS -0.11 (+0.02). Q3 so far rev down < 30%. Markets continuing to recover ahead of management expectations set in March. [SP=1.92 Cap=15m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Slice
Posts: 958
Joined: November 4th, 2016, 2:45 pm
Has thanked: 33 times
Been thanked: 902 times

Re: MrC's Smallcap Sweeps for Sept 2020

#339147

Postby MrContrarian » September 9th, 2020, 7:42 am

Smallcap Sweep. 09-Sep-20
WIN winnning

Somero Enterprises (SOM) H1 rev down 9%, pretax down 29%. div 4c (5.75c). Payment of deferred FY 2019 div 20.7c. Resume buyback. Guides FY rev $75m, adjusted EBITDA c.$19m. [SP=206.22 Cap=117m]
Newmark Security (NWT) FY(Apr) rev down 4%, pretax £231k (£214k) but post-tax £1.13m (£189k). No div. [SP=1.24 Cap=6m]
Haydale Graphene Industries (HAYD) £3m placing at 3.5p, a 29% discount, to keep the lights on. Board guides "a modest recovery for the current year." [SP=5.1 Cap=17m]
Amryt Pharma (AMYT) positive Phase III result from trial of its drug to speed wound healing in Epidermolysis Bullosa. Possible $1bn market. [SP=180 Cap=288m]
Wincanton (WIN) guides FY materially ahead of market expectations, assuming no further COVID-19 impact that severely affects the business. [SP=180 Cap=224m]
Quiz (QUIZ) gets agreement on rents payable predominantly based upon revenues on reopened stores. Rev Apr - Aug down 77%, margins 600bp lower. Even online rev down 54%. [SP=7.45 Cap=9m]
RM (RM.) return of all pupils to UK schools and colleges gives greater clarity, now guides all three divisions will be profitable in FY. CEO to leave in March. [SP=191 Cap=160m]
Powerhouse Energy (PHE) £5m placing at 2.5p, a 15% discount, to keep the lights on ("necessary cash resources for Powerhouse to reach profitability and to implement its wider strategy for international growth"). Peel Holdings taking £1m and gets warrant to buy £10.2m at 2.75p. Peel is "part of a group of companies with whom the Company has an exclusivity and licensing agreement." [SP=3 Cap=105m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Slice
Posts: 958
Joined: November 4th, 2016, 2:45 pm
Has thanked: 33 times
Been thanked: 902 times

Re: MrC's Smallcap Sweeps for Sept 2020

#339367

Postby MrContrarian » September 10th, 2020, 8:28 am

Smallcap Sweep. 10-Sep-20
WJA believe it.

Wameja (WJA) rec offer at 8p, a 39% premium. Many holders hoped for more from partner Mastercard. [SP=7.26 Cap=167m]
EPE Special Opps (ESO) NAV 345.7p/sh. [SP=208 Cap=65m]
Menzies(J) (MNZS) bank agrees revised covenants. Guides H1 rev down 33%. Co "re-starting operations and seeing a partial return of flight schedules. Cargo volumes continue to be more resilient and our AMI business, a cargo brokerage, is trading ahead of expectations given the current lack of available capacity." Some contract wins. [SP=117 Cap=99m]
Supply@Me Capital (SYME) claims to habve offers of funding to monetise more than €300m of inventory. Plus region updates. [SP=0.58 Cap=187m]
City of London Group (CIN) £30m placing at 80p, a 25% premium, for SME lending and to boost capital for banking license. [SP=64 Cap=26m]
ReNeuron (RENE) AGM stmt: patient dosing started in the expanded Phase 2a trial of hRPC cell therapy candidate for retinitis pigmentosa. Also "signed a further research evaluation agreement with a leading biotechnology company [for] Company's proprietary exosomes for the delivery of novel therapeutics." [SP=98.89 Cap=32m]
Prime People (PRP) guides FY(March) rev down 3%, pretax at least £1.8m (£2.47m). ""Since June there has been a modest increase in activity. However, half and full year profitability will be severely impacted. As a result of challenging trading, we expect to take a material reduction in the value of goodwill." [SP=47.9 Cap=6m]
LoopUp (LOOP) significant new contract with one of the world's top-5 law firms. Expands partnership with C&W Communications to 2022. Starts free plan for 10 people max "aimed at individual users within target market professional services firms, who experience the product as guests of existing customers." [SP=215 Cap=118m]
Speedy Hire (SDY) UK and Ireland core hire revenues for September to date down c.8%. Utilisation 52.9% (2019: 54.6%). Expects no staff on furlough beyond end Sept and other tax payments deferred as part of COVID-19 support measures will have been paid. [SP=53.83 Cap=284m]
Iconic Labs (ICON) has successfully completed a contract to produce research, data and insights for a multinational consumer goods company. Expects to extend JOE Media's contract to its newly acquired Irish operations. [SP=0.01 Cap=1m]
Science Group (SAG) guides FY adj op profit in line or slightly ahead of mgmt original expectations. Will pay interim div of 2p. [SP=242.9 Cap=101m]
U and I (UAI) gets £23m grant for first phase of delivery at Mayfield in Manchester which is expected to deliver c.£80-100m of profit and c.£40m in fees to U+I over its lifespan to c.2034. Other updates. [SP=64.2 Cap=80m]
TT Electronics (TTG) has been appointed exclusive manufacturing partner for the commercial launch of Virolens, a COVID-19 screening device using microscopic holographic imaging and AI to detect the virus from a saliva swab test within 20 seconds. Initial order worth £2m in Sept and Oct. iAbra has indicated its intent to purchase further devices and cartridges with associated revenue to TT of circa £280m. [SP=263.79 Cap=433m]
SAGA (SAGA) proposed £150m rescue placing. £60.6m at 27p from the ex CEO and the rest at a discount [SP=15.54 Cap=178m]
Epwin Group (EPWN) H1 ahead of earlier expectations;,optimistic for H2. [SP=76.12 Cap=108m]

In line: DEV
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Slice
Posts: 958
Joined: November 4th, 2016, 2:45 pm
Has thanked: 33 times
Been thanked: 902 times

Re: MrC's Smallcap Sweeps for Sept 2020

#339598

Postby MrContrarian » September 11th, 2020, 7:25 am

Smallcap Sweep. 11-Sep-20
Super quiet

Tungsten (TUNG) CFO resigns with immediate effect, for personal reasons. He is thanked. [SP=39.44 Cap=50m]
Belvoir (BLV) founder to place up to 5.7% of co at 150p min. [SP=163.8 Cap=57m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Slice
Posts: 958
Joined: November 4th, 2016, 2:45 pm
Has thanked: 33 times
Been thanked: 902 times

Re: MrC's Smallcap Sweeps for Sept 2020

#340121

Postby MrContrarian » September 14th, 2020, 7:45 am

Smallcap Sweep. 14-Sep-20


Symphony (SYM) H1 & trading: "more recent activity within our strong pipeline indicates a pick-up for the rest of the year and into 2021." Also further testing shows efficacy against viruses of d2p anti-microbial technology in plastic products. [SP=22.99 Cap=39m]
Brighton Pier Group (PIER) last 2 months rev down 23%, better than the Board expected. "The potential need to repurpose dancefloors and to seat customers in a socially distanced fashion, with an absence of live music and dancing, will fundamentally change the business model with significant reduction in capacity. Given the uncertainty surrounding reopening dates, the Group has been working on plans to trial this new model in some of its larger venues...encouraged." [SP=30 Cap=11m]
N4 Pharma (N4P) Covid-19 Proof of Concept Update: a single injection used in the stage 3 pre (pilot) in vivo study didn't result in desired effect but neither did the positive control. "Additional exploratory studies will continue to understand the translation potency of the Coronavirus plasmid including optimisation of Nuvec plasmid loading. With this in mind and taken together with previous positive data, the Company has decided to proceed to a full in vivo study." [SP=9.6 Cap=15m]
Aeorema Communications (AEO) opens first US office to better service US clients. Has also completed the development of its own virtual events platform. [SP=20.45 Cap=2m]
Focusrite (TUNE) guides FY(Aug) rev £129m, up 52%, ahead of market expectations. Core Focusrite Audio Engineering business rev up 23%. Will repay furlough cash. [SP=741 Cap=431m]
Surface Transforms (SCE) chosen as tier one supplier of a carbon ceramic brake disc on a vehicle by a global vehicle manufacturer. Est rev to 2024 c. £27.5m but no min. Guides FY rev £2m, £400k higher than market expectations. [SP=25.04 Cap=39m]
Seeing Machines (SEE) to launch driver monitoring system Kit on Qualcomm Snapdragon Automotive Platform. [SP=4.14 Cap=139m]
Fletcher King (FLK) FY rev doen 15%, adj EPS 12%. Outlook "It is very difficult to accurately assess our future trading performance in the current market conditions. It will be extremely challenging to remain profitable and it is very likely that the Company will make a loss in the first half of its financial year." [SP=31 Cap=3m]
EKF Diagnostics (EKF) H1(June) rev up 23%, pretax up 180%, div 1p( 0). FY likely to exceed management expectations. [SP=57.22 Cap=260m]
Colefax (CFX) FY(Apr). No div. Current sales trends are ahead of initial expectations at the start of the pandemic. [SP=392.8 Cap=36m]
Xpediator (XPD) H1(June) rev down 3%, adj pretax £2.1m, up 5%, div 0.45p (0.28p). Now trading close to normal levels. Guides FY adjusted profit at least flat. [SP=26.25 Cap=37m]

In line: TPX
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Slice
Posts: 958
Joined: November 4th, 2016, 2:45 pm
Has thanked: 33 times
Been thanked: 902 times

Re: MrC's Smallcap Sweeps for Sept 2020

#340338

Postby MrContrarian » September 15th, 2020, 7:40 am

Smallcap Sweep. 15-Sep-20


Bidstack (BIDS) has signed agreement with Ubisoft to deliver native in-game advertising for Hyper Scape, its futuristic, free-to-play, urban battle royale game, on PCs and consoles. [SP=5.05 Cap=20m]
Cerillion (CER) wins its largest ever contract, worth £11.2m, with a major UK provider of enterprise connectivity solutions. Majority of income, including software licences and services, is expected to be recognised in the next 12 months, and the contract has an overall term of five years. [SP=295 Cap=87m]
Eden Research (EDEN) gets first patent for Sustaine encapsulation technology ("Encapsulation of High Potency Actives"), in Australia, [SP=6.48 Cap=25m]
Evgen Pharma (EVG) licence agreement with Juvenescence for non-pharmaceutical applications. Worth $10.5m milestones plus royalties on sales. Monetises one element of Evgen's sulforaphane technology platform . [SP=12.49 Cap=17m]
Cohort (CHRT) continues to expect that FY trading will be in line with last FY. Order book £210.0m (£183.3m). [SP=616 Cap=252m]
Tex Holdings (TXH) proposes to delist after very long suspension after it was unable to supply audited accounts for FY18. Working with the Company's major shareholder on possible refinancing proposals. [SP=0 Cap=NA]
OptiBiotix Health (OPTI) grants US co exclusive license for large scale manufacture and commercialisation of a number of SweetBiotix® products. OPTI gets modest license payments until launch then royalties. [SP=49.94 Cap=44m]
Mountfield (MOGP) Tardy FY(Dec) out. Hunkers down in outlook: "Group Companies will take a cautious approach to securing their current and mid-term turnover targets and will concentrate on servicing the requirements of core clients on contracts which are neither onerous nor carry a significant risk element. The Board acknowledges that this policy will impact of turnover and net profit." [SP=0.9 Cap=2m]
Eve Sleep (EVE) H1(June) rev down 5%, pretax -£1.3m (-£6.7m). Notes very recently raised guidance. [SP=6.42 Cap=17m]
Good Energy (GOOD) H1(June) - U/L performance of the core business in line with management expectations. [SP=192 Cap=32m]
Corero Network Security (CNS) H1(June) rev up 48%, pretax -$2.7m (-$3.9m). Order intake, including Juniper resale partnership, building across H2, emand for DDoS solutions remain strong. [SP=8.42 Cap=42m]
Beeks Financial Cloud (FY(June) rev up 27%, U/L pretax up 8%. FY div flat. Outlook - "positive market environment and considerably increased sales pipeline, confident in securing additional Tier 1 customers in the year ahead." [SP=NA Cap=NA]

In line: AVG
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Slice
Posts: 958
Joined: November 4th, 2016, 2:45 pm
Has thanked: 33 times
Been thanked: 902 times

Re: MrC's Smallcap Sweeps for Sept 2020

#340541

Postby MrContrarian » September 16th, 2020, 7:48 am

Smallcap Sweep. 16-Sep-20


ClearStar (CLSU) rec offer 40p, a 23% premium. [SP=33.44 Cap=12m]
Tiziana Life Sciences (TILS) intends to demerge its StemPrintER and SPARE genomics-based personalised medicine business. Book value £3m. [SP=137 Cap=262m]
Immunodiagnostic Systems (IDH) launches four new i-Tracker® assays designed to run on its automated IDS-iSYS analyser to address the rapidly growing market of biologics drug monitoring. [SP=237.5 Cap=68m]
Eckoh (ECK) AGM stmt: special div 0.61p in lieu of the final dividend thanks to continued resilience of the business. [SP=67.45 Cap=171m]
Duke Royalty (DUKE) upturn experienced in the underlying trading of its royalty partner continues. Guides Q2 sash revenue (being cash distributions from its Royalty Partners and gains from sales of equity) will total £2.4m (Q1:£2m). [SP=27 Cap=67m]
Inspiration Healthcare (IHC) another £2m of ventilators delivered, total now £5m. [SP=64.5 Cap=44m]
Best of the Best (BOTB) guides FY ahead of previous management expectations. Bid discussions have resumed after summer pause. [SP=1625 Cap=152m]
RBG Holdings (RBGP) H1(June) rev up 17% but pretax only £1.4m (£3.2m). Profit hit by reduction of two high margin revenue streams. "However, much of this revenue has been deferred and the Group is well positioned for litigation investment sales and targeting M&A deals to be completed in H2." Passes div. Outlook "cautious about making future forecasts given the economic uncertainty." [SP=71.78 Cap=61m]
Eagle Eye Solutions(EYE) FY(June). Outlook in line. [SP=252 Cap=65m]
Checkit (CKT) H1(July) rev(cont) normalsed up 2.3%, pretax -£2m (-£3.1m). Co "remains confident about the outlook and has therefore reinstated financial guidance." I could not find it! [SP=46 Cap=29m]
Science in Sport (SIS) H1(June) rev down 5%, gross margin 47.7% (44.8%), pretax -£2.6m (-£3.1m). Recent 2 months rev up 1%. "Major projects in supply chain and technology are underway, to help support the next phase of digital and international growth." [SP=36 Cap=49m]
Accesso Technology (ACSO) H1(June) rev down 51%, ahead of mgmt revised expectations. Pretax -$18.5m (-$4.6m). $46.1m raised in May unspent. Recent trading continued slightly ahead of mgmt expectations: nearly 80% of Passport and over 60% of LoQueue supported venues reopened with reduced capacities. [SP=286 Cap=118m]
ASA International (ASAI) Collection efficiency remained in the mid to high nineties in eight operating countries which give over 70% of the pre-tax profit. Moratorium loans total $40.7m, 10% of outstanding loan portfolio. Pipeline of funding deals under negotiation c. $220m. [SP=175 Cap=175m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Slice
Posts: 958
Joined: November 4th, 2016, 2:45 pm
Has thanked: 33 times
Been thanked: 902 times

Re: MrC's Smallcap Sweeps for Sept 2020

#340807

Postby MrContrarian » September 17th, 2020, 7:49 am

Smallcap Sweep. 17-Sep-20


Supply@ME Capital (SYME) co "is aware that a totally erroneous article reviewing a series of fabricated SYME forecasts was issued yesterday afternoon. This appeared on more than one "fake news" website." Expect to announce more detailed updates on its inventory funding in a few days. The article was on ProNewsReport according to ShareProphets. [SP=0.54 Cap=160m]
Tiziana Life Sciences (TILS) plans clinical study of nasally administered Foralumab in COVID-19 patients, alone or in combination with orally administered dexamethasone. Hopes to start in a few weeks. [SP=145 Cap=277m]
Dev Clever (DEV) 3 year commercial partnership with Low6, a leading provider of mobile pool betting applications. Low6 is in the final stages of implementing its 'PubWars' application, in partnership with SKY, across 1,300 new venues in the UK. £115k fee + slice of rev. [SP=8.78 Cap=41m]
WANdisco (WAND) LiveData migrator launch with Amazon Web Services. No £££. [SP=574 Cap=301m]
Morses Club (MCL) trading H1 'sales' £51.2m (£82.2m). "Making good progress in accelerating its strategy of serving its customers via remote methods of lending and collection...Despite a face-to-face alternative being available, remote lending still represented over 50% of loan volumes issued in August." [SP=53 Cap=70m]
Ten Lifestyle Group (TENG) guides FY(Aug) rev slightly ahead of market expectations of £43.3m and adj EBITDA slightly ahead of market expectations of £4.5m. [SP=82 Cap=66m]
Eden Research (EDEN) Cedroz and the biofungicide, Mevalone authorised in France. Mevalone authorised for use on table and wine grapes in Serbia. [SP=6.8 Cap=26m]
Trakm8 (TRAK) AGM stmt - improving trend continued, guides H1 rev down 18%. Rev down 7% in July and August, new orders up 9% YTD. Fleet attrition rate inc to 9%. H2 will benefit from the resumption of a more normal level of Fleet activity and a significant increase in the Insurance shipments. [SP=16.4 Cap=8m]
FIH Group (FIH) AGM stmt - guides FY U/L loss lower than expected in June. [SP=300 Cap=36m]
Novacyt (NCYT) H1 and reiterates July guidance: FY rev €150 million and EBITDA over €100m. Expects this rate of financial performance to extend into H1 2021. [SP=370 Cap=288m]
Safestyle (SFE) H1. growth in order intake recently matched by delivering a 20% increase in survey, processing, manufacturing and fit capacity, will enable double digit rev growth in H2. "The operational challenges linked to recovery and growth have adversely impacted customer service levels post-lockdown and investment is now underway to address this rapidly." No FY guidance yet. [SP=54 Cap=72m]
Surgical Innovations (SUN) £1.8m placing at 1.6p, an 11% discount, to keep the lights on. [SP=1.86 Cap=14m]

In line: BEG
Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian

MrContrarian
Lemon Slice
Posts: 958
Joined: November 4th, 2016, 2:45 pm
Has thanked: 33 times
Been thanked: 902 times

Re: MrC's Smallcap Sweeps for Sept 2020

#341121

Postby MrContrarian » September 18th, 2020, 7:43 am

Smallcap Sweep. 18-Sep-20


Falanx (FLX) wins US contract for its Cybersecurity monitoring services. Initial revenues are not yet material but potential to grow significantly with the addition of further devices and services. [SP=1.29 Cap=5m]
Accsys Technologies (AXS) last 5 months rev down 6% on volume down 9%. Expects recovery in sales to continue assuming no further significant disruption from COVID. [SP=93.6 Cap=154m]
Everyman Media (EMAN) CEO resigns, stays for handover as non director. He is thanked. [SP=84.2 Cap=77m]
SpaceandPeople (SAL) CEO & co-founder scarpers. He is thanked. Other co-founder appointed CEO to ensure continuity of disappointments. [SP=5.15 Cap=1m]
Intelligent Ultrasound (MED) FDA submission for canNav AnatomyGuide Peripheral Nerve Block (PNB) artificial intelligence-based software. Co aiming for initial revenues in H2. [SP=13.5 Cap=36m]
Trackwise Designs (TWD) 3 year contract with a UK manufacturer of electric vehicles that has the potential to be worth up to £5m in 2021, and with the expectation of increased revenues in 2022 and 2023. Follows initial order of £0.6m announced in Feb. [SP=115.5 Cap=26m]
AB Dynamics (ABDP) guides FY(Aug) rev £60-62m. Plans FY div. Co anticipates order recovery towards pre-COVID levels will continue into the new year, provided there are no further significant market disruptions. Share-based payment charge (c. £1.3m) will now not be excluded from adj profit. [SP=1920 Cap=433m]
MediaZest (MDZ) second interim results (12 months to Mar): rev down 27%, posttax -£271k (+£6k). Outlook: enquiries still below normal level. "Board is working on the assumption that the disruption caused by the Pandemic will have an impact deep into 2021 and continues to plan accordingly, searching for new revenue streams whilst managing costs carefully." Shares unsuspended. [SP=0.04 Cap=1m]
Zinc Media (ZIN) second interim results: rev down 51%, pretax -£2.1m (-£2.1m). Confident of profit and cash positive in H2 even if revenue doesn't fully recover to pre-Covid-19 levels. [SP=66.9 Cap=5m]
Integumen (SKIN) H1(June) rev £1m up 290%, pretax £-955k (-£974k). Guides Q3 rev >£1m, keeps FY(18 months) guidance at £4m. [SP=35.5 Cap=40m]


Notes SP & cap are 20m delayed
DYOR, E&OE etc etc. I may have a position in any or all of the shares covered.

RNSs
http://www.investegate.co.uk/index.aspx?limit=-1

@MrContrarian


Return to “Share ideas”

Who is online

Users browsing this forum: No registered users and 14 guests